Participate in the Congress on Immunotherapy and Infectious Diseases Meeting
The objective of this two-day congress is to promote interactions between pharmaceutical industries, research laboratories, service providers, technology developers and clinicians, thus contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.
I4ID2024 will build on the success of previous editions, the first having taken place in 2017, with more than 1,520 participants from different countries representing more than 500 organizations and 265 internationally renowned speakers discussing immunotherapy and new therapeutic approaches to combat against infectious diseases.
The I4ID2024 program includes conferences, presentations of new innovative projects, pharmaceutical companies and posters.
Different networking opportunities are available to you, particularly through presentations of new products and technologies for businesses, and our online BtoB platform will allow you to discuss future commercial partnerships!
Take advantage of Early Bird until July 24 and, as a member of Lyonbiopole, a discount on your pass!